Business Wire

Fresenius Kabi Launches RFID-Enabled Rocuronium Bromide Injection, its First Product Compatible with Bluesight's KitCheck System

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a leading provider of injectable medications, announced today it has launched Rocuronium Bromide Injection with advanced RFID-enabled labels in the ...
Morningstar

Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has launched Rocuronium Bromide Injection Room Temperature ...
Monthly Prescribing Reference

FDA: Vial Caps of Two Neuromuscular Blocking Agents May Not Have Warning Statement

The Food and Drug Administration (FDA) is notifying healthcare professionals regarding the temporary absence of the “paralyzing agent” warning statement on vial caps of vecuronium bromide for ...
FierceBiotech

Sagent Pharmaceuticals Announces Two New FDA Approvals: Sumatriptan Succinate Injection and Rocuronium Bromide Injection

SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...
Yahoo Finance

Fresenius Kabi Introduces First-Ever Rocuronium Bromide Injection Stable at Room Temperature

LAKE ZURICH, Ill., December 18, 2025--(BUSINESS WIRE)--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has ...
Pharmabiz

Fresenius Kabi launches rocuronium bromide injection stable at room temperature

Fresenius Kabi, an operating company of Fresenius, and a leading provider of essential medicines and medical technologies, announced it has launched rocuronium bromide injection room temperature ...